Dr. Sarah Dotters-Katz is a maternal-fetal medicine specialist and obstetrician and gynecologist at Duke Health in Durham, N.C. One of her research interests is clinical infectious diseases and how they impact pregnancy.
Dr. Sarah Dotters-Katz is a maternal-fetal medicine specialist and obstetrician and gynecologist at Duke Health in Durham, N.C. One of her research interests is clinical infectious diseases and how they impact pregnancy.
In this video, Dr. Dotters-Katz discusses her perspective on COVID-19’s impact on pregnant patients with Senior Editor Angie DeRosa. Dotters-Katz also includes what she is seeing in her area of the United States. She has been very active in spreading her knowledge. She wrote a commentary in the April issue of Contemporary OB/GYN with Dr. Brenna Hughes, entitled, “COVID-19: The pathogen that will define the decade.”
She and Dr. Hughes also did a review recently for the American Journal of Perinatology, “Considerations for obstetric care during the COVID-19 pandemic,” in which they discussed the key points that COVID-19 severity in pregnancy is unclear and social distancing is the best protective mechanism. There is no clear evidence that vertical transmission exists. If a mother is positive, then mother/ baby separation avoids transmission. That article abstract can be found here.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
How genetic variables impact oral contraceptive use and VTE risk
March 27th 2024A comprehensive study delved into the interplay of polygenic and hereditary factors in venous thromboembolism risk among oral contraceptive users, shedding light on potential genetic markers for refined risk assessment and counseling.
Read More
Higher preterm birth risk found following cesarean delivery at full dilation
March 26th 2024Recent research highlights an association between cesarean delivery at full dilation and increased risk of subsequent preterm birth, prompting further investigation into childbirth practices and outcomes.
Read More